Baluarte, Antonio .

HRN: 00-65-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/03/2022
12/09/2022
IV
1.5g
Q6
CAP-MR, T/C PTB Relapse
Waiting Final Action 
12/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/06/2022
12/12/2022
IV
4.5g IVT Now ANST Then 2.25g IVT Q8
4.5g IVT Now ANST Then 2.25g IVT Q8
CAP MR; T/C PTB Relapse; Bilateral Pleural Effusion More On Right
Waiting Final Action 
12/08/2022
CLARITHROMYCIN 500MG (CAP)
12/08/2022
12/14/2022
ORAL
500mg
BID
CAP MR; Right Lung Atelectasis
Waiting Final Action 
12/15/2022
LEVOFLOXACIN 500MG (TAB)
12/15/2022
12/21/2022
PO
750mg
OD
CAP MR COPD In AE
Waiting Final Action 
11/29/2023
CEFTRIAXONE 1G (VIAL)
11/29/2023
12/06/2023
IV
2g
Q24H
CAP MR
Waiting Final Action 
11/29/2023
AZITHROMYCIN 500MG TABLET (TAB)
11/29/2023
12/03/2023
ORAL
500mg/tab
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: